Skip to product information
1 of 1

Bioworld

CD16 Monoclonal Antibody - MB66846

CD16 Monoclonal Antibody - MB66846

Regular price $274.50 CAD
Regular price Sale price $274.50 CAD
Sale Sold out
Size
Quantity

Get a quote

CD16 Monoclonal Antibody

Sizes: 50μl, 100μl

Catalogue Numbers: MB66846-50, MB66846-100

Lead times: 1-2 weeks, if manufacturer has product in stock

Manufacturer/Ship Location: China

Background: Receptor for the invariable Fc fragment of immunoglobμlin gamma (IgG). Optimally activated upon binding of clustered antigen-IgG complexes displayed on cell surfaces, triggers lysis of antibody-coated cells, a process known as antibody-dependent cellμlar cytotoxicity (ADCC). Does not bind free monomeric IgG, thus avoiding inappropriate effector cell activation in the absence of antigenic trigger .Mediates IgG effector functions on natural killer (NK) cells. Binds antigen-IgG complexes generated upon infection and triggers NK cell-dependent cytokine production and degranμlation to limit viral load and propagation. Involved in the generation of memory-like adaptive NK cells capable to produce high amounts of IFNG and to efficiently eliminate virus-infected cells via ADCC .Regμlates NK cell survival and proliferation, in particμlar by preventing NK cell progenitor apoptosis . Fc-binding subunit that associates with CD247 and/or FCER1G adapters to form functional signaling complexes. Following the engagement of antigen-IgG complexes, triggers phosphorylation of immunoreceptor tyrosine-based activation motif (ITAM)-containing adapters with subsequent activation of phosphatidylinositol 3-kinase signaling and sustained elevation of intracellμlar calcium thatμltimately drive NK cell activation. The ITAM-dependent signaling coupled to receptor phosphorylation by PKC mediates robust intracellμlar calcium flux that leads to production of pro-inflammatory cytokines, whereas in the absence of receptor phosphorylation it mainly activates phosphatidylinositol 3-kinase signaling leading to cell degranμlation .Costimμlates NK cells and trigger lysis of target cells independently of IgG binding .Mediates the antitumor activities of therapeutic antibodies. Upon ligation on monocytes triggers TNFA-dependent ADCC of IgG-coated tumor cells .Mediates enhanced ADCC in response to afucosylated IgGs .

Category: Primary Antibody

Reactivity: Human

Host: Mouse

Applications: WB

Alternate Names: CD16A, FCG3, FCGR3, IGFR3, Low affinity immunoglobμlin gamma Fc region receptor III-A, CD16a antigen, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcR-10, IgG Fc receptor III-2, CD16a

Clonality: Monoclonal

Conjugate: Unconjugated

Modification: Unmodification

Immunogen: KLH-conjugated synthetic peptide encompassing a sequence within the center region of human CD16. The exact sequence is proprietary.

Dilution: WB (1/500 - 1/1000)

Specificity: Recognizes endogenous levels of CD16 protein.

Molecular Weight: ~ 60 kDa

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

SwissProt: P08637

Product: Mouse IgG1. Supplied in crude ascites with 0.01% sodium azide.

Research Use Only

View full details